Eli Lilly's Foundayo showed 57.1% greater A1C reduction than oral semaglutide in trials Foundayo led to 73.6% more weight loss compared to oral semaglutide in type 2 diabetes patients Foundayo can be taken anytime, with or without food, unlike other diabetes pills